600535 Tasly Pharmaceutical Group

Watchlist

14.97
+0.19+1.29%

Not Open Mar 27 15:00 CST

22.36BMarket Cap23.39P/E (TTM)

About Tasly Pharmaceutical Group Company

The company is a leading international enterprise in modern traditional Chinese medicine, and is committed to developing into a leading integrated pharmaceutical and health service solution provider with global influence in China. We are “people-oriented, precise and innovative”, continuously promote the progress of medicine and health services, so that everyone can enjoy the beauty and hope of life to the fullest. The company belongs to the pharmaceutical manufacturing industry. Its main business is R&D, production and sales of pharmaceuticals. Main products: Compound Danshen Dropping Pills, Serum Nourishing Brain Pellets, Astragalus Ginseng Yiqi Droplets, Injectable Yiqi Fumei, Shuilin Jia. The company won the “2024 Top 100 Pharmaceutical Industry Comprehensive Competitiveness”, “2024 Top 50 Comprehensive Competitiveness in the Proprietary Chinese Medicine Industry”, “2023 Top 100 Chinese Pharmaceutical Enterprises”, “2024 China's Top 50 Comprehensive Pharmaceutical Companies”, “2024 China's Top 10 Traditional Chinese Medicine R&D Strength”, “2024 China's Top 100 Chemical Pharmaceutical R&D Strength”, “2024 China's Top 50 Biopharmaceutical R&D Strength Companies”, “2024 Top 50 Chinese Biopharmaceutical Research and Development Strength Companies”, “2024 Top 50 Independent Innovation Companies in the Pharmaceutical Industry”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Companies”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Companies”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Companies”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Companies”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Companies”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Companies”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Companies”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Companies”, “2024 Top 50 Chinese Pharmaceutical Industry Independent Innovation Honorary awards such as “Top 100 Pharmaceutical Industry Companies with Revenue in 2024”.

Company Profile

Short Name-A天士力

Symbol-A600535

Company NameTasly Pharmaceutical Group Co., Ltd

Listing DateAug 23, 2002

Issue Price14.70

Shares Offered50.00M share(s)

FoundedApr 30, 1998

Listed ExchangeSH Stock Exchange

Legal Representativekaijing yan

General Managerjinyong cai

Secretaryjie yu

Accounting FirmTianjian Certified Public Accountants (Special General Partnership)

Securities Representativeying zhao

Legal CounselInner Mongolia Jianzhong Law Firm

Employees5442

Phone022-26736999

Office AddressNo. 2, Puji River East Road, Beichen District, Tianjin (Tianshili Modern Traditional Chinese Medicine City)

Zip Code300410

Registered AddressNo. 2, Puji River East Road, Beichen District, Tianjin (Tianshili Modern Traditional Chinese Medicine City)

Fax022-26736721

Emailstock@tasly.com

Websitehttp://www.taslypharma.com

Business License120000000001246

BusinessLicense items: pharmaceutical production; road cargo transportation (network freight); road cargo transportation (excluding dangerous goods); drug retail [branch operation]; pharmaceutical wholesale [branch operation]. (Projects requiring approval according to law can only be carried out after approval by relevant departments; specific business projects are subject to documents or licenses approved by relevant departments) General projects: medical research and experimental development; road cargo transportation by ordinary freight vehicles with a total mass of 4.5 tons or less (excluding network freight and dangerous goods); technology import and export; import and export of goods; technical services, technology development, technical consulting, technical exchange, technology transfer, technology promotion [branch office operation]; business training (excluding training requiring permission for education and training, vocational skills training, etc.) [Branch office operation]. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with law)

Company Executives

Name
Position
Salary

kaijing yan
Chairman, Directors, Member of the Nomination, Remuneration and Assessment Committee, Chairman of the Strategy Committee, Audit Committee Member
2.82M